Literature DB >> 10180134

International Conference on Harmonisation; guidance on ethnic factors in the acceptability of foreign clinical data; availability--FDA. Notice.

.   

Abstract

The Food and Drug Administration (FDA) is publishing a guidance entitled "E5 Ethnic Factors in the Acceptability of Foreign Clinical Data". The guidance was prepared under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The guidance recommends regulatory and development strategies to permit clinical data collected in one region to be used for the support of drug and biologic registrations in another region while allowing for the influence of ethnic factors.

Entities:  

Mesh:

Year:  1998        PMID: 10180134

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  14 in total

Review 1.  Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.

Authors:  Mei-Ling Chen
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 2.  Pharmacogenetics in drug regulation: promise, potential and pitfalls.

Authors:  Rashmi R Shah
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-08-29       Impact factor: 6.237

Review 3.  Axitinib plasma pharmacokinetics and ethnic differences.

Authors:  Ying Chen; Akiyuki Suzuki; Michael A Tortorici; May Garrett; Robert R LaBadie; Yoshiko Umeyama; Yazdi K Pithavala
Journal:  Invest New Drugs       Date:  2015-02-08       Impact factor: 3.850

4.  Statistical design of noninferiority multiple region clinical trials to assess global and consistent treatment effects.

Authors:  Guoqing Diao; Donglin Zeng; Joseph G Ibrahim; Alan Rong; Oliver Lee; Kathy Zhang; Qingxia Chen
Journal:  J Biopharm Stat       Date:  2017-03-15       Impact factor: 1.051

5.  Design and analysis of bridging studies with prior probabilities on the null and alternative hypotheses.

Authors:  Donglin Zeng; Zhiying Pan; D Y Lin
Journal:  Biometrics       Date:  2019-11-21       Impact factor: 2.571

6.  Lack of ethnic differences in the pharmacokinetics and pharmacodynamics of evolocumab between Caucasian and Asian populations.

Authors:  Chen Wang; Qingshan Zheng; Mingqiang Zhang; Hong Lu
Journal:  Br J Clin Pharmacol       Date:  2018-10-17       Impact factor: 4.335

7.  Globalization of Alzheimer's disease clinical trials.

Authors:  Jeffrey Cummings; Robert Reynders; Kate Zhong
Journal:  Alzheimers Res Ther       Date:  2011-08-17       Impact factor: 6.982

Review 8.  Artemisinin-based combination therapy in the treatment of uncomplicated malaria: review of recent regulatory experience at the European Medicines Agency.

Authors:  Eric Pelfrene; Marie-Hélène Pinheiro; Marco Cavaleri
Journal:  Int Health       Date:  2015-04-08       Impact factor: 2.473

9.  Pharmacokinetics, safety and tolerability of rotigotine transdermal patch in healthy Japanese and Caucasian subjects.

Authors:  Willi Cawello; Seong R Kim; Marina Braun; Jan-Peer Elshoff; Junji Ikeda; Tomoo Funaki
Journal:  Clin Drug Investig       Date:  2014-02       Impact factor: 2.859

Review 10.  Multi-regional clinical trials and global drug development.

Authors:  Premnath Shenoy
Journal:  Perspect Clin Res       Date:  2016 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.